KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Assets (2018 - 2025)

ClearPoint Neuro's Assets history spans 13 years, with the latest figure at $60.4 million for Q3 2025.

  • For Q3 2025, Assets rose 50.17% year-over-year to $60.4 million; the TTM value through Sep 2025 reached $60.4 million, up 50.17%, while the annual FY2024 figure was $39.2 million, 8.14% down from the prior year.
  • Assets for Q3 2025 was $60.4 million at ClearPoint Neuro, down from $62.9 million in the prior quarter.
  • Across five years, Assets topped out at $74.3 million in Q1 2021 and bottomed at $30.1 million in Q1 2025.
  • The 5-year median for Assets is $55.5 million (2022), against an average of $54.7 million.
  • The largest annual shift saw Assets surged 214.87% in 2021 before it tumbled 43.94% in 2025.
  • A 5-year view of Assets shows it stood at $65.6 million in 2021, then decreased by 15.39% to $55.5 million in 2022, then fell by 23.12% to $42.7 million in 2023, then dropped by 8.14% to $39.2 million in 2024, then soared by 54.02% to $60.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Assets are $60.4 million (Q3 2025), $62.9 million (Q2 2025), and $30.1 million (Q1 2025).